Intriguingly, the CCA marker KRT19 and the PROX1 targets PRRX1 and PPARG exhibited a negative correlation with PROX1 expression in tumor tissue (Fig. 7b), suggesting that PROX1 could regulate liver cancer plasticity and HCC versus CCA fate. This evidence concerns the gene PROX1 and hepatocellular carcinoma.